The Taiwan Food and Drug Administration (TFDA) on Saturday asked the public to refrain from procuring GLP-1 and GIP weight-loss medications from unknown sources, after the United Kingdom issued a heightened warning about the drugs last week.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
DPP township council candidate dies after collapsing on stage
09/23/2026 11:52 AM - Science & Tech
Taiwan part of WorldSkills Competition opening ceremony in China
09/23/2026 10:53 AM - Business
U.S. dollar down in Taipei trading
09/23/2026 10:17 AM - Society
Taiwan headline news
09/23/2026 10:05 AM - Business
Taiwan shares open higher
09/23/2026 09:15 AM